Artelo Biosciences, Inc.
ARTL
$1.04
$0.010.97%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.78M | -1.13M | -2.43M | -2.48M | -3.07M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 176.00K | 154.00K | 124.00K | 115.00K | 62.00K |
| Change in Net Operating Assets | 1.04M | 200.00K | 246.00K | -574.00K | 415.00K |
| Cash from Operations | -2.57M | -778.00K | -2.06M | -2.94M | -2.60M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 500.00K | 4.25M | 1.75M | 1.27M | 2.74M |
| Cash from Investing | 500.00K | 4.25M | 1.75M | 1.27M | 2.74M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 57.00K | 0.00 | 0.00 | 55.00K | 32.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 57.00K | 0.00 | 0.00 | 55.00K | 32.00K |
| Foreign Exchange rate Adjustments | -9.00K | 4.00K | -1.00K | -2.00K | -1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.02M | 3.48M | -314.00K | -1.62M | 176.00K |